CA 125 Test Market by Spectrometer, Analyzer, Sample Collection Tube, Etc. Devices and Forecast to 2023

“CA 125 Test Market”
CA 125 Test Market Information: By Devices (Spectrometer, Analyzer, Sample Collection Tube, Otopic Labeled Peptides), Indication (Cancer, Uterine Fibroid, Endometriosis), By End User (Hospitals & Clinics, Diagnostic Centers) – Global Forecast till 2023

Cancer Antigen (CA) test is used to diagnose various disease such as cancer, uterine fibroids, endometriosis, and liver disease. CA 125 is a protein that is found in the blood. The test is mostly widely used of the diagnosis of ovarian cancer in women. Normal levels of CA 125 in the blood is less 30 units per ml. and elevated levels for CA 125 signals the presence cancer in the ovary. Besides diagnosis, the CA 125 test is also used for monitoring ovarian cancer, as well as for screening ovarian cancer in women suspected to be at high risk for developing the disease. The global CA 125 Test Market is blooming and is expected to grow at a CAGR of 5.7% during the forecast period.

Increasing demand for cancer diagnosis and treatment services, rising prevalence of cancer among the women and increasing emphasis on women healthcare. Furthermore, extensive diagnostic tests for cancer, also fuel the market growth. The growth of the market is restrained by the high cost of devices used in cancer diagnostics.

Get a Sample Report @ .

According to the American Cancer Society, in 2015, ovarian cancer represents only 3% of all malignancies in the U.S. women. Also there is a rise in the death rate due to various types of cancer of reproductive tract in women. Additionally, in the U.S., 22,280 women were estimated to have received an ovarian cancer diagnostic services and 14,240 deaths.

Key Players in the Global CA 125 Test Market 

Some of the key players in this market are Allergan plc. (U.K), Amgen Inc. (U.S.), Bayer (Germany), BD (U.S.), Eli Lilly Company (U.S.) , Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Private Limited (Israel), AMAG Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Sanofi (France), Novartis (Germany), AbbVie Inc. (U.S.), GlaxoSmithKline plc. (U.S.), and others.

Regional Analysis of the Global CA 125 Test Market                

America holds the first position in the market for CA 125 test owing to the rising prevalence of ovarian cancer in the U.S. and Canada. Additionally, the availability of a wide range of diagnosis and treatment methods for cancer and technological advancement in the field of oncology, also support the growth of the market in American countries. Presence of key player in the market also accelerates the growth of the market. These players are engaged in various strategic approaches such as mergers, acquisition, collaborations, partnership, and research activities, leading to the development of the market in North America.

In Europe, the market shows extensive growth owing to extensive research and development activities, and increasing demand for new medical devices for diagnosis of cancer drive the growth of the market. Germany, U.K, and France acquire first, second and third place respectively, in the European CA 125 test market.

Order Single User License Copy of 110 Premium Pages is Available @ .

The market in Asia Pacific is expected to grow at the fastest pace whose market is driven rising awareness about reproductive health and diseases among women, and improving healthcare infrastructure. Availability of highly qualified healthcare professionals such as physicians, surgeons and gynecologist in the developing regions such as India, Japan and China further fuel the market.

The Middle East & Africa also show a steady rise in the market owing to low prevalence of ovarian cancer, rising demand for diagnostic services and growing emphasis on diagnosis and treatment of cancer disease. Developing healthcare infrastructure in the Middle East also fuels the growth of the market. In the Middle East & Africa, the Middle East accounts for the largest market share owing to the availability of better healthcare services in the Middle East countries than in Africa.

Brief TOC

  1. Report Prologue  
  2. Market Introduction    
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global CA 125 test Market, by Device and Accessories
  7. Global CA 125 test Market, by Indication     
  8. Global CA 125 test Market, by End User
  9. Global CA 125 test Market, by Region
  10. Company Landscape  
  11. Company Profiles    
  12. MRFR Conclusion  
  13. Appendix

Ask to Expert @ .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India